The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Hendrik Ungefroren; Björn Konukiewitz; Ulrich F. Wellner; Jörg Schrader; Tobias Keck

doi:10.3390/cancers15010160

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Hendrik Ungefroren^*, Björn Konukiewitz, Ulrich F. Wellner, Jörg Schrader, Tobias Keck

^*Corresponding author for this work

Abstract

Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

Original language	English
Article number	160
Journal	Cancers
Volume	15
Issue number	1
ISSN	2072-6694
DOIs	https://doi.org/10.3390/cancers15010160
Publication status	Published - 01.2023

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)
Centers: University Cancer Center Schleswig-Holstein (UCCSH)
Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

2.22-25 General and Visceral Surgery
2.22-14 Hematology, Oncology
2.22-17 Endocrinology, Diabetology, Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers15010160

Cite this

@article{fcdc2d8b29b441f3b67c945b118f65c3,

title = "The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses",

abstract = "Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5\% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].",

author = "Hendrik Ungefroren and Bj{\"o}rn Konukiewitz and Wellner, \{Ulrich F.\} and J{\"o}rg Schrader and Tobias Keck",

year = "2023",

month = jan,

doi = "10.3390/cancers15010160",

language = "English",

volume = "15",

journal = "Cancers",

issn = "2072-6694",

number = "1",

}

TY - JOUR

T1 - The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

AU - Ungefroren, Hendrik

AU - Konukiewitz, Björn

AU - Wellner, Ulrich F.

AU - Schrader, Jörg

AU - Keck, Tobias

PY - 2023/1

Y1 - 2023/1

N2 - Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

AB - Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

UR - https://www.scopus.com/pages/publications/85145929498

UR - https://www.mendeley.com/catalogue/2ce1912b-273c-3782-8b94-fc263b509628/

U2 - 10.3390/cancers15010160

DO - 10.3390/cancers15010160

M3 - Editorial

C2 - 36612156

AN - SCOPUS:85145929498

SN - 2072-6694

VL - 15

JO - Cancers

JF - Cancers

IS - 1

M1 - 160

ER -

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Abstract

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this